Share on Facebook Share on Twitter Share on Google Plus Share on Pinterest Share on Linkedin

Diagnostic Tests for Digestive Disorders at Tampa General Hospital

Many different tests for digestive disorders exist that help doctors accurately diagnose conditions afflicting a patient’s digestive system. To investigate the pancreas, liver, gall bladder, and gastrointestinal (GI) tract, doctors often use advanced diagnostic testing procedures and imaging technologies.  

When doctors need to examine the digestive system directly for gastrointestinal tract disorders, they use viewing and testing devices that go inside the hollow organs of the GI tract. Diagnostic testing for digestive disorders that allow direct investigation of the GI tract include:

  • Anal manometry
  • Colonoscopy
  • Esophageal function studies
  • Gastrointestinal endoscopy

In addition to these direct tests for digestive disorders, doctors can use X-rays to image different portions of the digestive system and look for abnormalities. Some of these procedures include:

  • Arteriography
  • Endoscopic retrograde cholangiopancreatography (ERCP)
  • Intestinal transit studies
  • Spiral CT scanning

Ultrasonography also allows doctors to image the digestive system, and the following ultrasound procedures may be used:

  • Duplex ultrasound
  • Endoscopic ultrasound
  • Laparoscopic ultrasound

Magnetic Resonance Imaging (MRI) is another diagnostic imaging tool used for investigating digestive conditions. MRIs generate images that contain information not provided by X-rays and ultrasounds.

Tampa General Hospital’s Endoscopy Center has the advanced technology required to conduct these tests for digestive disorders, and TGH has been recognized by U.S. News & World Report as one of America's Best Hospitals for Gastroenterology & GI Surgery (ranked #24) as well as Best Florida Hospital for Gastroenterology & GI Surgery in 2020-2021. Our team of gastrointestinal surgeons, colorectal surgeons, medical oncologists, and other specialists works hard to diagnose correctly the digestive conditions affecting our patients. The Joint Commission has also awarded our benign esophageal disorders program and our pancreatic, hepatic, and biliary cancer programs with disease-specific certification.